HOME ABOUT US MEDICAL EDUCATION CLINICAL TRIALS PRODUCTS NEWS & EVENTS SUPPORT PARTNERS
Cardiac Biomarker Company Critical Diagnostics Completes $8.5 Million Financing And Announces Two Promotions
Critical Diagnostics Inks Exclusive Worldwide License Agreement For New Heart Failure Biomarker sNEP
Critical Diagnostics Announces Key Promotions
Multiple Studies Show Superiority of Critical Diagnostics’ ST2 Over BNP, NT-proBNP and Other Heart Failure Biomarkers
New Generation of Drugs Hold Great Promise in Saving and Improving the Lives of Millions of Heart Failure Patients
Critical Diagnostics’ Presage® ST2 Assay Cardiac Biomarker Test Receives China Food and Drug Administration Clearance
Heart Failure Study Performed by Cleveland Clinic Shows Serial Testing with Cardiac Biomarker ST2 Predicts Outcomes of Hospitalized Patients
Opinions of 18 World-Renowned Experts Contained in Consensus Paper on Role of Cardiac Biomarker ST2 in Heart Failure Care
Critical Diagnostics Launches Rapid Test for Managing Heart Failure Patients
New White Paper Reveals Cardiovascular Pandemic Affecting Tens of Millions of People Worldwide
Critical Diagnostics Begins 2015 With Landmark Reimbursement and CPT Coding Decisions For Its Heart Failure Biomarker, ST2
The Pandemic Called Heart Failure White Paper
To view digital copy, please click here